Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01756586 · ClinicalTrials.gov registry record · Phase 4
Dexamethasone and Lower Extremity Block Duration
A Phase 4 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 4
- Development phase
- 4
- Enrollment target
NCT01756586 is a Phase 4 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 4 participants.
The verdict
NCT01756586, a Phase 4 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 4 participants
- Enrollment target
Study Summary
Dexamethasone has shown to prolong upper extremity blocks. No one ha studied its effect on lower extremity blocks. The study would evaluate that point.
Interventions
- DRUG Bupivacaine
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01756586
The ClinicalTrials.gov registry entry for NCT01756586 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT01756586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01756586 about?
NCT01756586 is a clinical study titled "Dexamethasone and Lower Extremity Block Duration". Dexamethasone has shown to prolong upper extremity blocks. No one ha studied its effect on lower extremity blocks. The study would evaluate that point.
What is the current status of trial NCT01756586?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 4 participants. The study started on 2013-02. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01756586?
The interventions under investigation include: Bupivacaine (DRUG), Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT01756586?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.